Citius Pharmaceuticals, Inc.(“Citius”) (“Company”) (“CTXR”), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company completed the largest capital raise in its history of $10 million, and insiders were responsible for supporting 50% of the raise.
August 15, 2018
· 4 min read